362 related articles for article (PubMed ID: 28407405)
41. Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-κB signaling pathways: implications for intervertebral disc degeneration.
Li Z; Wang X; Pan H; Yang H; Li X; Zhang K; Wang H; Zheng Z; Liu H; Wang J
Osteoarthritis Cartilage; 2017 Feb; 25(2):341-350. PubMed ID: 27737814
[TBL] [Abstract][Full Text] [Related]
42. Cyclopropanyldehydrocostunolide LJ attenuates high glucose-induced podocyte injury by suppressing RANKL/RANK-mediated NF-κB and MAPK signaling pathways.
Chen XW; Liu WT; Wang YX; Chen WJ; Li HY; Chen YH; Du XY; Peng FF; Zhou WD; Xu ZZ; Long HB
J Diabetes Complications; 2016 Jul; 30(5):760-9. PubMed ID: 27052152
[TBL] [Abstract][Full Text] [Related]
43. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
[TBL] [Abstract][Full Text] [Related]
45. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
[TBL] [Abstract][Full Text] [Related]
46. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
[TBL] [Abstract][Full Text] [Related]
47. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis.
Das R; Kim SJ; Nguyen NT; Kwon HJ; Cha SK; Park KS
Kidney Int; 2019 Oct; 96(4):927-941. PubMed ID: 31377057
[TBL] [Abstract][Full Text] [Related]
49. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
50. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
51. Mechanical challenges and cytoskeletal impairments in focal segmental glomerulosclerosis.
Feng D; DuMontier C; Pollak MR
Am J Physiol Renal Physiol; 2018 May; 314(5):F921-F925. PubMed ID: 29363327
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-135a is involved in podocyte injury in a transient receptor potential channel 1-dependent manner.
Yang X; Wu D; Du H; Nie F; Pang X; Xu Y
Int J Mol Med; 2017 Nov; 40(5):1511-1519. PubMed ID: 28949388
[TBL] [Abstract][Full Text] [Related]
53. Role of Protease-Activated Receptor 2 in Regulating Focal Segmental Glomerulosclerosis.
Wang Y; He Y; Wang M; Lv P; Liu J; Wang J
Cell Physiol Biochem; 2017; 41(3):1147-1155. PubMed ID: 28245472
[TBL] [Abstract][Full Text] [Related]
54. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
55. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
[TBL] [Abstract][Full Text] [Related]
56. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
[TBL] [Abstract][Full Text] [Related]
57. Plekhh2, a novel podocyte protein downregulated in human focal segmental glomerulosclerosis, is involved in matrix adhesion and actin dynamics.
Perisic L; Lal M; Hulkko J; Hultenby K; Önfelt B; Sun Y; Dunér F; Patrakka J; Betsholtz C; Uhlen M; Brismar H; Tryggvason K; Wernerson A; Pikkarainen T
Kidney Int; 2012 Nov; 82(10):1071-83. PubMed ID: 22832517
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease.
Verzola D; Bonanni A; Sofia A; Montecucco F; D'Amato E; Cademartori V; Parodi EL; Viazzi F; Venturelli C; Brunori G; Garibotto G
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):131-144. PubMed ID: 27897392
[TBL] [Abstract][Full Text] [Related]
59. Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss.
Dai R; Liu H; Han X; Liu J; Zhai Y; Rao J; Shen Q; Xu H
BMC Nephrol; 2019 May; 20(1):185. PubMed ID: 31126248
[TBL] [Abstract][Full Text] [Related]
60. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
